Literature DB >> 18670734

Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.

Claudia Mendoza-Pinto1, Mario García-Carrasco, Hilda Sandoval-Cruz, Ricardo O Escárcega, Mario Jiménez-Hernández, Ivet Etchegaray-Morales, Elena Soto-Vega, Margarita Muñoz-Guarneros, Aurelio López-Colombo, Margarita Delezé-Hinojosa, Ricard Cervera.   

Abstract

The aim of this study was to determine the prevalence and risk factors for low bone mineral density (BMD) in women with systemic lupus erythematosus (SLE). A cross-sectional study was conducted among 100 pre-menopausal patients with SLE. Patients were evaluated using a questionnaire about the following variables: age, disease duration, disease activity, chronic disease damage, cumulative corticosteroid dose, and history of fracture. Lumbar spine and hip measurements of BMD were performed by dual absorptiometry. Univariate and multivariate statistical analyses were used to assess the relationship between risk factors and BMD. The mean age was 32.8 +/- 8.7 years, and the median duration of SLE was 73.2 +/- 65 months. The mean cumulative corticosteroid dose was 20.0 +/- 21.3 g. The mean BMD was 1.09 +/- .18 g/cm(2) in the lumbar spine and 1.0 +/- .14 g/cm(2) in the hip. Osteopenia was present in 40% of patients and osteoporosis in 5%. In the multiple regression analysis, low BMD in the lumbar spine was associated with chronic disease damage and low body mass index (BMI). Low BMD in the hip was associated with cumulative corticosteroid dose and low BMI. Chronic disease damage, low BMI, and cumulative corticosteroid dose are risks factors for low BMD in pre-menopausal SLE patients. Osteopenia was found in 40% of patients, while osteoporosis was found in only 5%.

Entities:  

Mesh:

Year:  2008        PMID: 18670734     DOI: 10.1007/s10067-008-0984-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  43 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage.

Authors:  A Becker; R Fischer; W A Scherbaum; M Schneider
Journal:  Lupus       Date:  2001       Impact factor: 2.911

3.  Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus.

Authors:  H P Bhattoa; E Kiss; P Bettembuk; A Balogh
Journal:  Rheumatol Int       Date:  2001-11       Impact factor: 2.631

4.  Bone mineral density changes in women with systemic lupus erythematosus.

Authors:  M Boyanov; R Robeva; P Popivanov
Journal:  Clin Rheumatol       Date:  2003-10       Impact factor: 2.980

5.  Loss of trabecular bone mineral density in systemic lupus erythematosus.

Authors:  A A Kalla; A B Fataar; S J Jessop; L Bewerunge
Journal:  Arthritis Rheum       Date:  1993-12

6.  Predictors of bone mineral density in female workers in Morelos State, Mexico.

Authors:  Alma Ethelia López-Caudana; Martha María Téllez-Rojo Solís; Mauricio Hernández-Avila; Patricia Clark; Sergio Arturo Juárez-Márquez; Eduardo César Lazcano-Ponce; Jorge Salmerón-Castro
Journal:  Arch Med Res       Date:  2004 Mar-Apr       Impact factor: 2.235

7.  Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Watanabe; M Suzuki; K Saito; S Oda; H Suzuki; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

8.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

View more
  10 in total

1.  Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Authors:  J Jacobs; L-A Korswagen; A M Schilder; L H van Tuyl; B A C Dijkmans; W F Lems; A E Voskuyl; I E M Bultink
Journal:  Osteoporos Int       Date:  2012-10-03       Impact factor: 4.507

2.  Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.

Authors:  C-C Lai; W-S Chen; D-M Chang; Y-P Tsao; T-H Wu; C-T Chou; C-Y Tsai
Journal:  Osteoporos Int       Date:  2014-10-01       Impact factor: 4.507

Review 3.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico.

Authors:  América G Uribe; Juanita Romero-Díaz; Mandar Apte; Mónica Fernández; Paula I Burgos; John D Reveille; Jorge Sánchez-Guerrero; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-08-28       Impact factor: 7.580

5.  Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus.

Authors:  Yu Mori; Kazuyoshi Baba; Atsushi Kogure; Takuya Izumiyama; Michiharu Matsuda; Naoko Mori; Tomonori Ishii; Eiji Itoi
Journal:  J Orthop       Date:  2018-01-31

6.  Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Authors:  Sofia Ajeganova; Thomas Gustafsson; Tomas Jogestrand; Johan Frostegård; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2015-03-25       Impact factor: 5.156

7.  Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus.

Authors:  Yi-Ning Sun; Xiu-Yuan Feng; Lan He; Ling-Xia Zeng; Zhi-Ming Hao; Xiao-Hong Lv; Dan Pu
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

Review 8.  Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

Authors:  Irene E M Bultink
Journal:  Calcif Tissue Int       Date:  2017-09-12       Impact factor: 4.333

Review 9.  Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.

Authors:  Claudia Mendoza-Pinto; Adriana Rojas-Villarraga; Nicolás Molano-González; Erick A Jiménez-Herrera; María de la Luz León-Vázquez; Álvaro Montiel-Jarquín; Mario García-Carrasco; Ricard Cervera
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

10.  Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage.

Authors:  A Barbulescu; F A Vreju; C Criveanu; A Rosu; P Ciurea
Journal:  Curr Health Sci J       Date:  2015-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.